HIPRA

Empresa Premium

258 Seguidores 10 Publicaciones 3 Siguiendo

HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service.

A company that works with the latest technological advances to create innovative solutions that improve world health.

R&D projects are the basis of the knowledge. HIPRA has more than 50 years of experience dedicated to the research and development of different vaccines. With a unique organizational model, HIPRA controls all the processes of the value chain, generating singular know-how and becoming a reference in the research, production, and commercialization of biologics.

HIPRA has a solid international presence, commercial subsidiaries and a global distribution network, allowing products to reach costumers from more than 100 countries, covering the 5 continents.

Actinobacilosis/Pleuroneumonía porcina Aujeszky Autovacunas Circovirus -PCV Clostridiosis Colibacilosis Glaesserella parasuis/Enfermedad de Glässer Influenza/gripe Mal Rojo/Erisipelas Mycoplasma/Neumonía enzoótica Parvovirus PRRS Rinitis Atrófica Software

Enviar mensaje

https://www.hipra.com

hipra@hipra.com

+34 972430660

Av. La Selva, 135
17170 GIRONA
España

HIPRA

258 Seguidores 10 Publicaciones 3 Siguiendo

Actividad Productos 17 Eventos 1 Publicaciones 10 Artículos patrocinados en 333 78

Key considerations for managing neonatal diarrhea: A practical approach

Neonatal diarrhea in piglets is a critical challenge in swine production. This practical webinar will address key prevention and management strategies to effectively control this disease.

Evento grabado